Vivanta Generics s.r.o. secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient abiraterone (excluding potency 500 mg), ATC L02BX03 for the period 01102024 - 30092026

Czechia, Oct. 2 -- Czechia based Vivanta Generics s.r.o. has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient abiraterone (excluding potency 500 mg), ATC L02BX03 for the period 01102024 - 30092026 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....